Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00528 |
| Species: | Homo sapiens |
| Position : | chr1:191100000-191150000 |
| Year: | 2024 |
| Title: | Enhancer infestation drives tumorigenic activation of inactive B compartment in Epstein-Barr virus-positive nasopharyngeal carcinoma |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | nasopharyngeal carcinoma |
| PMID: | 38490101 |
| MONDO: | MONDO:0005350 |
| Tissue: | Nasopharyngeal epithelium |
| Tissue Ontology ID: | UBERON:0008338 |
| Cell Source: | C666-1 |
| CVCL ID: | CVCL_7949 |
| Cell Type: | nasopharyngeal carcinoma cell |
| Cell Ontology ID: | CL:0000069 |
| Experiment Type: | Enhancer activity assay, Chromatin interaction assay, Functional perturbation assay |
| High Throughput Method: | Hi-C, 4C-seq, ChIP-seq, RNA-seq |
| Low Throughput Method: | siRNA Knockdown, RT-RT-qPCR, Western blot, IHC |
| Target gene : | PLA2G4A |
| TF name : | SMAD3; REL |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|